Lonza Group AG (LONN-SW) Buy, Sell or Hold

Lonza Group AG (LONN-SW)

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

0.00

-0.00 (0.00%)

23 watching

PAST TOP PICK

(A Top Pick Apr 07/20, Up 39%) Contract producer of pharmaceuticals. Leader in making biotech drugs. 2020 was so strong, he got out, since 2021 couldn't compare. Rate of growth will be lower next year, but he will revisit it.

TOP PICK

Price target: 400.94 SFr A contract producer of pharmaceuticals, the biggest maker of biotech drugs and small-molecule drugs (pills). Chinese and Indian competitors are unreliable (receiving FDA notices), so Lonza is capturing market share who are reliable.

PAST TOP PICK

(A Top Pick Oct 29/18, Up 7%) A Swiss company manufacturing pharmaceuticals under contract for other companies. Biotech is the fastest area of growth in the health space. They are able to avoid the politicization of drug manufacturing in this role.

TOP PICK

They make drug ingredients. They take a drug from the development stage through to the production stage on behalf of a biotech or pharma company. They are a global low cost producer and own some of the enabling technology. (Analysts’ target: CHF 345.93).

Showing 1 to 4 of 4 entries

Lonza Group AG (LONN-SW) Frequently Asked Questions

What is Lonza Group AG stock symbol?

Lonza Group AG is a OTC stock, trading under the symbol LONN-SW on the undefined (undefined). It is usually referred to as or LONN-SW

Is Lonza Group AG a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on LONN-SW on Stockchase. Read the latest expert commentary for Lonza Group AG.

Is Lonza Group AG a good investment or a top pick?

Lonza Group AG was recommended as a Top Pick by David Fingold on 2018-10-29. Read the latest stock experts ratings for Lonza Group AG.

Why is Lonza Group AG stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Lonza Group AG.

Is Lonza Group AG worth watching?

Lonza Group AG is followed by 23 investors on Stockchase and is a trending stock that is worth watching.

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Richard Orrell

RN Croft Financial Group

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Lonza Group AG (LONN-SW)